Dihydrocodeine BPM Phenyleph HCl and Mogamulizumab-kpkc Intravenous
Determining the interaction of Dihydrocodeine BPM Phenyleph HCl and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dihydrocodeine / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydrocodeine BPM Phenyleph HCl-Molindone
- Dihydrocodeine BPM Phenyleph HCl-Mometasone (Oral Inhalation)
- Dihydrocodeine BPM Phenyleph HCl-Mometasone and Formoterol
- Dihydrocodeine BPM Phenyleph HCl-Mometasone and formoterol Inhalation
- Dihydrocodeine BPM Phenyleph HCl-Mometasone Cream
- Dihydrocodeine BPM Phenyleph HCl-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Dihydrocodeine, Aspirin, and Caffeine
- Mogamulizumab-kpkc Intravenous-Dihydroergotamine
- Mogamulizumab-kpkc Intravenous-Dihydroergotamine injection
- Mogamulizumab-kpkc Intravenous-Dihydroergotamine Mesylate
- Mogamulizumab-kpkc Intravenous-Dihydroergotamine nasal
- Mogamulizumab-kpkc Intravenous-Dihydroergotamine Nasal Spray